| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 9.091 | 11.433 | 11.260 | 11.406 | 118 | 3.234 | 15.937 | 12.384 | 11.172 |
| Total Income - EUR | - | 9.091 | 11.433 | 11.260 | 11.406 | 118 | 3.246 | 15.937 | 12.384 | 11.172 |
| Total Expenses - EUR | - | 4.084 | 6.490 | 5.997 | 18.994 | 7.002 | 4.939 | 12.885 | 5.482 | 5.463 |
| Gross Profit/Loss - EUR | - | 5.007 | 4.943 | 5.263 | -7.588 | -6.884 | -1.694 | 3.052 | 6.902 | 5.709 |
| Net Profit/Loss - EUR | - | 4.735 | 4.714 | 4.944 | -7.819 | -6.885 | -1.746 | 2.574 | 5.600 | 4.771 |
| Employees | - | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Venomed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | 0 | 0 | 443 | 241 | 47 | 0 | 859 | 1.367 |
| Current Assets | - | 5.033 | 9.598 | 14.325 | 9.095 | 6.303 | 541 | 1.286 | 6.718 | 8.848 |
| Inventories | - | 0 | 215 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 26 | 875 | 2.316 | 3.658 | 4.144 | 385 | 0 | 962 | 383 |
| Cash | - | 5.007 | 8.507 | 12.009 | 5.437 | 2.159 | 156 | 1.286 | 5.756 | 8.465 |
| Shareholders Funds | - | 4.779 | 9.412 | 14.072 | 5.981 | -1.018 | -2.742 | -176 | 5.424 | 10.165 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 253 | 220 | 253 | 3.557 | 7.584 | 3.373 | 1.622 | 2.197 | 106 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Venomed Srl